Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

Metformin 4Clomiphene 3Sperm Injections, Intracytoplasmic 2Progesterone 2Letrozole 2Hydrocortisone 2Estradiol 2semaglutide 1Progestins 1Ovidrel 1Menotropins 1Medroxyprogesterone Acetate 1Leuprolide 1Insulin 1In Vitro Oocyte Maturation Techniques 1Human Growth Hormone 1Growth Hormone 1Gonadotropins 1Diet, Vegetarian 1Diet, Vegan 1Dexamethasone 1Cosyntropin 1Caloric Restriction 1Blood Specimen Collection 1Angptl4 protein, mouse 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Polycystic Ovary Syndrome × semaglutide × Clear all
NCT06222437 2026-03-23

Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy

Methodist Health System

Phase 1 Withdrawn

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡